Investment details
Entry
Staff
208Location
FranceGimv supports us in various operations, going from external growth to strategic investments and development concepts. It is truly an all-encompassing support, both financially and strategically.
Olivier Derouard
Group President
Partnership Gimv
Gimv invested in SGH Medical out of the conviction that the company is an excellent platform for developing a leading European player in the medical plastics sector consisting of pharmaceutical and medical device capabilities that deliver high quality and have a critical size. Growth is realised via both an active acquisition strategy, for example the acquisition of Rovipharm and RR Plastiques back in 2018, and organic growth.



